Unmarried people - whether single, divorced/separated or widowed - have a higher risk of having depressive symptoms than married people, says an international study. The paper, published in Nature Human Behaviour, includes data from more than 100,000 adults in China, Indonesia, Ireland, Korea, Mexico, the UK, the USA and the UK.
A phase 2 clinical trial has tested the efficacy and safety of a transcranial magnetic stimulation device used at home to treat major depression in 174 patients. After dividing them into two groups, one group received the treatment and the other a placebo procedure. After ten weeks, both groups had improved their symptoms, but the improvement in the active treatment group was 0.4 points greater on the Hamilton depression scale. According to the authors, who publish the results in the journal Nature Medicine, ‘it could potentially serve as a first-line treatment for major depression’.
Ahead of World Suicide Prevention Day on September 10, a new series of six articles published in The Lancet Public Health calls for a shift in the narrative. Experts advocate for moving beyond framing suicide solely as a mental health issue, emphasizing the need to recognize the impact of social factors such as poverty, debt, addiction, homelessness, abuse, discrimination, and social isolation.
A brain study of 23 people with treatment-resistant depression while they listen to classical music has identified the antidepressant mechanisms of this music. Using intracranial recordings and electroencephalogrammes, the researchers concluded that listening to classical music synchronises neuronal oscillations between the auditory cortex - responsible for processing sensory information - and the reward circuit - responsible for processing emotional information. "The improvement of depressive symptoms was not linked to the emotion of the music itself but was correlated with the patient’s level of music enjoyment," says the study published in Cell Reports.
Research published in JAMA Network Open suggests that exposure to common environmental toxicants is associated with depressive symptoms. The authors analysed data from urine or blood samples from more than 3,400 US adults and found that 27 environmental toxicants were associated with these symptoms, which could be linked to inflammatory processes.
The use of the antidepressants escitalopram, paroxetine, and duloxetine is associated with greater weight gain than the use of sertraline, according to the results of an analysis comparing data from more than 183,000 adults treated with one of eight types of antidepressants. Among these, bupropion is associated with the least weight gain, concludes the study, which is published in Annals of Internal Medicine.
Ketamine extended-release tablets are effective, safe and well tolerated in patients with depression resistant to other treatments, according to a phase 2 clinical trial. Compared to intranasal or intravenous use of ketamine, these oral tablets are easier to administer and would provide less dissociative intensity, lower risk of abuse and cardiovascular adverse effects, the authors write in Nature Medicine.
The Lancet Psychiatry publishes the first meta-analysis of the incidence of antidepressant treatment discontinuation symptoms that includes data from more than 20,000 patients collected from 79 randomised controlled trials and observational studies. The study sought to distinguish between symptoms directly caused by medication discontinuation and other ‘non-specific’ symptoms that may be associated with patient or professional expectations (the nocebo effect). The study concludes that one in six to seven patients will experience one or more symptoms directly caused by stopping medication, and one in 35 are likely to experience severe symptoms.
A dose of psilocybin—a hallucinogenic substance—administered to groups of 3 or 4 people suffering from cancer and depression may help reduce their depressive symptoms, according to a clinical trial conducted in the United States. The study involved 30 patients who also received individual and group therapeutic support. In another article, also published in the journal Cancer, the authors examine how the study participants perceived the therapy.
An international team, led by the Hospital Clínic-IDIBAPS in Barcelona together with King's College London (UK) and Dalhousie University (Canada), has published the largest meta-analysis to date studying the risk of children of people with mental disorders developing the same, or another type of disorder. The study included more than three million children of parents with different types of disorders and more than 20 million people as a control population. The results, published in the journal World Psychiatry, indicate that, overall, the former have a 1.5 to 3 times higher risk of developing a disorder in their lifetime. According to the authors, in the case of bipolar, depressive or anxiety disorders, the risk of their offspring suffering from some type of disorder is more than 50%.